Literature DB >> 17093998

Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema.

Atul Kumar1, Subijay Sinha, Rajvardhan Azad, Yog Raj Sharma, Rajpal Vohra.   

Abstract

BACKGROUND: The purpose of this study is to compare the effectiveness of pars plana vitrectomy (PPV) and dye-enhanced peeling of the internal limiting membrane (ILM) with modified grid laser photocoagulation in patients with diffuse diabetic macular edema and to determine if any correlation exists between improvement in visual acuity (functional improvement) and reduction in foveal thickness and macular volume (anatomical improvement).
DESIGN: This is a randomized, prospective, comparative, interventional study.
METHOD: In this study 24 eyes of 24 patients with metabolically stable diabetes and with diffuse diabetic macular edema were evaluated. The patients were randomized to either pars plana vitrectomy with removal of ILM which was done in 12 eyes (ILM group) and modified grid laser photocoagulation carried out in the remaining 12 eyes (laser group). Main outcome measures were (1) the postoperative visual acuity in the form of ETDRS log MAR values, (2) foveal thickness and (3) macular volume as measured by optical coherence tomography. The correlation between improvement in visual acuity and the reduction of foveal thickness and macular volume in both the groups were also evaluated. The results were all subjected to statistical analysis.
RESULTS: The ETDRS log MAR visual acuity difference between the two groups at the end of 6 months was not clinically significant (P = 0.525). However, foveal thickness and macular volume decreased significantly more in the ILM group compared to the laser group (P = 0.001, P < 0.001, Mann Whitney U test). There was no correlation between the improvement in visual acuity and the reduction of foveal thickness (r = -0.158, P = 0.6) (ILM group), r = -0.155, P = 0.7) (laser group) in both groups.
CONCLUSIONS: PPV with ILM peeling was shown to be beneficial by inducing a statistically significant reduction of macular thickness and macular volume. Visual acuity also demonstrated a trend towards improvement in both the ILM peel group and the grid laser group; however, the comparative VA outcome analysis between the two groups was not significantly different. Besides, there was also no correlation between the reductions of foveal thickness and macular volume with the improvement in visual acuity in either of the groups.

Entities:  

Mesh:

Year:  2006        PMID: 17093998     DOI: 10.1007/s00417-006-0456-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  27 in total

1.  Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid.

Authors:  T Ikeda; K Sato; T Katano; Y Hayashi
Journal:  Retina       Date:  2000       Impact factor: 4.256

2.  Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid.

Authors:  S D Pendergast; T S Hassan; G A Williams; M S Cox; R R Margherio; P J Ferrone; B R Garretson; M T Trese
Journal:  Am J Ophthalmol       Date:  2000-08       Impact factor: 5.258

3.  A controlled study of vitrectomy for diabetic macular edema.

Authors:  Tomohiro Otani; Shoji Kishi
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

4.  Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.

Authors:  Brett J Rosenblatt; Gaurav K Shah; Sanjay Sharma; Jeff Bakal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-07-31       Impact factor: 3.117

5.  Vitrectomy for diffuse macular edema in cases of diabetic retinopathy.

Authors:  N Tachi; N Ogino
Journal:  Am J Ophthalmol       Date:  1996-08       Impact factor: 5.258

6.  Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.

Authors:  A Gandorfer; E M Messmer; M W Ulbig; A Kampik
Journal:  Retina       Date:  2000       Impact factor: 4.256

7.  Vitrectomy with peeling of the inner limiting membrane for treating diabetic macular edema.

Authors:  D Kolacny; R Parys-Vanginderdeuren; A Van Lommel; P Stalmans
Journal:  Bull Soc Belge Ophtalmol       Date:  2005

8.  Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema.

Authors:  R J Olk
Journal:  Ophthalmology       Date:  1986-07       Impact factor: 12.079

9.  Effects of internal limiting membrane peeling in vitrectomy on diabetic cystoid macular edema patients.

Authors:  Yumi Kamura; Yukihiro Sato; Takako Isomae; Hiroyuki Shimada
Journal:  Jpn J Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 2.447

10.  Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results.

Authors:  C M Lee; R J Olk
Journal:  Ophthalmology       Date:  1991-10       Impact factor: 12.079

View more
  13 in total

1.  Prediction of postoperative visual outcome after pars plana vitrectomy based on preoperative multifocal electroretinography in eyes with diabetic macular edema.

Authors:  Yong Min Kim; Soo Young Lee; Hyoung Jun Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-06       Impact factor: 3.117

2.  Histopathologic analysis of the internal limiting membrane surgically peeled from eyes with diffuse diabetic macular edema.

Authors:  Kaoru Tamura; Toshiyuki Yokoyama; Nobuyuki Ebihara; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2012-03-23       Impact factor: 2.447

3.  Review of therapeutic advances in diabetic retinopathy.

Authors:  Chirag P Shah; Carolyn Chen
Journal:  Ther Adv Endocrinol Metab       Date:  2011-02       Impact factor: 3.565

4.  Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes.

Authors:  Norihito Doi; Taiji Sakamoto; Yasushi Sonoda; Miho Yasuda; Koji Yonemoto; Noboru Arimura; Eisuke Uchino; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-19       Impact factor: 3.117

5.  Pharmacologic therapies for diabetic retinopathy and diabetic macular edema.

Authors:  Ehud Rechtman; Alon Harris; Hanna J Garzozi; Thomas A Ciulla
Journal:  Clin Ophthalmol       Date:  2007-12

Review 6.  Diabetic macular edema: what is focal and what is diffuse?

Authors:  David J Browning; Michael M Altaweel; Neil M Bressler; Susan B Bressler; Ingrid U Scott
Journal:  Am J Ophthalmol       Date:  2008-09-05       Impact factor: 5.258

7.  Transconjunctival 25-gauge pars plana vitrectomy and internal limiting membrane peeling for chronic macular edema.

Authors:  Minhee Cho; Donald J D'Amico
Journal:  Clin Ophthalmol       Date:  2012-07-06

8.  Pars plana vitrectomy for diabetic macular edema. Internal limiting membrane delamination vs posterior hyaloid removal. A prospective randomized trial.

Authors:  Hans Hoerauf; Anne Brüggemann; Manuela Muecke; Julia Lüke; Maya Müller; Einar Stefánsson; Hans-Peter Hammes; Claudia Weiss
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-18       Impact factor: 3.117

9.  Combined vitrectomy and intravitreal injection versus combined laser and injection for treatment of intractable diffuse diabetic macular edema.

Authors:  Ahmed M Saeed
Journal:  Clin Ophthalmol       Date:  2013-02-14

10.  Pars Plana Vitrectomy with Internal Limiting Membrane Peeling for Nontractional Diabetic Macular Edema.

Authors:  Jan Niklas Ulrich
Journal:  Open Ophthalmol J       Date:  2017-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.